TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
ATAI

AtaiBeckley Inc.

Healthcare · Biotechnology

7.40$ +0.0% vs. previous close Closing price · As of: Sep 11, 2026

Ownership

Ownership Structure

Who owns AtaiBeckley Inc. (ATAI)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 83.2% of the shares are freely tradable; institutional investors hold 44.8%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 44.8%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 2.3%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 83.2%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 6.1%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 371Mio.

Largest Shareholders

Institutions

Institutions ATAI
Name Stake (%) Shares Change (%) Date
Deep Track Capital, LP 3.89 14,417,442 +20.1 06/30/2026
Vanguard Capital Management, LLC 3.17 11,761,398 +0.0 03/31/2026
UBS Group AG 2.00 7,426,867 +0.0 03/31/2026
BlackRock Inc 1.84 6,835,300 +0.0 03/31/2026
Adage Capital Partners Gp LLC 1.52 5,642,758 +0.0 06/30/2026
Susquehanna International Group, LLP 1.43 5,286,326 +0.0 03/31/2026
Morgan Stanley - Brokerage Accounts 1.04 3,852,772 +0.0 03/31/2026

Funds

Funds ATAI
Name Stake (%) Shares Change (%) Date
Vanguard MStar Total Stk Mkt Idx Invest 2.48 9,212,714 +0.2 07/31/2026
iShares Russell 2000 ETF 2.19 8,138,078 -0.6 08/31/2026
ARK Genomic Revolution 1.16 4,297,820 +4.4 06/30/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Insiders

Insider Transactions

Insider Transactions
Date Person Role Type Shares Price Value
Sep 11, 2026 Craig Kevin James Chief Medical Officer Other 8,437
Sep 11, 2026 Rao Srinivas See remarks Other 3,500
Sep 11, 2026 Rao Srinivas See remarks Other 212,942
Sep 11, 2026 Johnson Anne Nagengast Chief Accounting Officer Other 140,045
Sep 11, 2026 Barrett Christopher Ryan Cave See remarks Other 155,066
Sep 11, 2026 Short Glenn Frank Chief Scientific Officer Other 42,333
Sep 11, 2026 Kalali Amir H Director Other 4,666
Sep 11, 2026 Smiley Andrea Heslin Director Other 4,666
Sep 11, 2026 Angermayer Christian Director Other 1,799,302
Sep 11, 2026 Angermayer Christian Director Other 53,398,214
Sep 11, 2026 Angermayer Christian Director Other 559,232
Apr 20, 2026 Kevin James Craig Insider Sell 42,579 5.00 212,895

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →

Data as of: September 11, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?